订阅小程序
旧版功能

A Randomized, Open-Label, Two-Cycle, Two-Crossover Phase I Clinical Trial Comparing the Bioequivalence and Safety of Afatinib and Giotrif® in Healthy Chinese Subjects.

Guangwen Liu,Jinling Xue,Yanli Wang,Zhengzhi Liu,Xue Li,Dongmei Qu,Zhengjie Su,Kaibo Xu,Xinyao Qu, Zhaojuan Qu,Linlin Sun, Mingming Cao, Ying Wang,Xuesong Chen,Jing Yu,Lang Liu,Qiaohuan Deng,Yicheng Zhao,Lixiu Zhang,Haimiao Yang

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY（2023）

引用 0|浏览18
关键词
Afatinib,Bioequivalence,Generic drug,Lung cancer,Epidermal growth factor
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要